Effect of Empagliflozin on Ambulatory Blood Pressure Monitoring (ABPM)

Effect of Empagliflozin on Ambulatory Blood Pressure Monitoring (ABPM) - Effect of Empagliflozin on ABPM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022109

Enrollment

Registered

2018-05-01

Start date

2016-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetics Mellitus Hypertension

Interventions

Empagliflozin DPP4 Inhibitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with DM and Hypertension

Exclusion criteria

Exclusion criteria: eGFR<30ml/min/1.73m2 Liver Dysfunction

Design outcomes

Primary

Measure	Time frame
Change of 24 hour blood pressure	—

Secondary

Measure	Time frame
Changes of fast blood glucose and HbA1c Change of renal function	—

Countries

Japan

Contacts

Public ContactHidetomo Nakamoto

Saitama Medical University Department of General Internal Medicine

nakamo_h@saitama-med.ac.jp049-276-1667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026